HomeAboutRequest an AppointmentEye Conditions Services & Procedures VideoEye Classic Contact Us
Services & Procedures

Selective Laser Trabeculoplasty (SLT)

Breakthrough Technology
The SLT treatment is a highly effective approach for first-line glaucoma treatments, adjunct therapy with drugs, and alternative therapy when drugs fail. The Solo uses short pulses of low-energy light to target the melanin in specific cells of the affected eye. In response, the body’s natural healing mechanisms rebuild these cells, improving drainage and lowering intraocular pressure. The surrounding, non-pigmented cells – as well as the rest of the eye structure –are untouched and undamaged.

Selective Laser Trabeculoplasty (SLT) is one of the greatest advances in the surgical treatment of intraocular pressure (IOP) in patients with open – angle glaucoma.

This repeatable, non-invasive treatment promotes cellular regeneration without the burn and scar tissue associated with other laser procedures. Prior to the introduction, medications and argon laser trabeculoplasty (ALT) were the opthalmologist’s primary tools.

Physicians and patients are benefiting from the SLT procedure in the following ways:

Safety and efficacy
SLT is safe and effective, and is not associated with systemic adverse effects.

Patient compliance is not an issue
SLT is performed by a physician and does not require patient compliance between physician visits

Cost effective
SLT provides economic benefits for the patient and the physician. Laser trabeculoplasty is a Medicare-covered procedure and is reimbursable under CPT code 65855.

Latest technology
New short-pulse, low fluence selective technology of the Selecta system provides pressure-lowering effects for your patients without compliance risks or systemic side effects.

Because of the specific wavelength of light generated, as well as the power and duration of the exposure, SLT selectively targets pigmented cells in the trabecular meshwork and causes no discernable damage to adjacent tissue. Researchers have found treated and untreated tissue to be nearly indistinguishable.*

The intracellular microdisruption triggered by the laser is confined to the targeted cells. The laser activates specific biological mechanisms and minimizes thermal diffusion to surrounding non-pigmented cells, rather than coagulating or ablating tissue. The laser pulse is so short that heat caused within the targeted cells doesn't have time to spread to surrounding tissue.*

* Source: Ophthalmology Management, July 2000


Top Top